Aster DM Healthcare Ltd posted a consolidated net profit of ₹79 crore for Q4 FY25 against a net loss of ₹24 crore in the year ago quarter. The company reported revenue from operations at ₹1,000 crore, up 2.7%YoY over ₹973.6 crore reported in Q4 FY24.
EBITDA increased 20.3% to ₹191.7 crore in the March 2025 quarter from ₹159.4 crore a year ago. EBITDA margin was 19.2%, compared with 16.4% in the year-ago quarter. With established brand names, Aster DM Healthcare’s network across India and the GCC comprises 13 hospitals, 110 clinics and 238 pharmacies.
In the National Stock Exchange, shares of Aster DM Healthcare has dipped 4% from the previous close. The stock has gained 54% in the last one year, and 10% in the last month.
Dr. Azad Moopen, Founder and Chairman of Aster DM Healthcare said, “Our Q4 performance reflects continued focus on operational excellence and patient-centric care. We are also excited about the transformative potential of our merger with Quality Care, which will significantly enhance our scale and capabilities.”
The company has also proposed merger with Quality Care India Ltd which is currently under regulatory approvals. In its exchange filing, the company has said that it has received approvals from shareholders, stock exchanges and competition commission of India (CCI). The transaction may complete by Q4FY26 as there is a pending approval from NCLT.
Related Tags
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.